UK markets open in 1 hour 28 minutes

Silence Therapeutics plc (SLNCF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
3.25000.0000 (0.00%)
At close: 03:58PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 349.96M
Enterprise value 242.06M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)15.37
Price/book (mrq)8.51
Enterprise value/revenue 14.99
Enterprise value/EBITDA -5.61

Trading information

Stock price history

Beta (5Y monthly) 0.28
52-week change 3-56.51%
S&P500 52-week change 3-10.10%
52-week high 329.8500
52-week low 31.3200
50-day moving average 31.8498
200-day moving average 35.2670

Share statistics

Avg vol (3-month) 3145
Avg vol (10-day) 3520
Shares outstanding 5107.68M
Implied shares outstanding 6N/A
Float 825.37M
% held by insiders 156.74%
% held by institutions 127.76%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin -223.90%
Operating margin (ttm)-299.04%

Management effectiveness

Return on assets (ttm)-27.85%
Return on equity (ttm)-143.23%

Income statement

Revenue (ttm)16.15M
Revenue per share (ttm)0.17
Quarterly revenue growth (yoy)6.80%
Gross profit (ttm)4.96M
EBITDA -48.06M
Net income avi to common (ttm)-36.16M
Diluted EPS (ttm)-0.5280
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)90.02M
Total cash per share (mrq)0.84
Total debt (mrq)499k
Total debt/equity (mrq)1.46
Current ratio (mrq)4.38
Book value per share (mrq)0.32

Cash flow statement

Operating cash flow (ttm)-34.25M
Levered free cash flow (ttm)-29.71M